Predicted protein targets (top 11)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | MEP1B | Q16820 | 1/20 | 0.32 |
| ▸ | ACLY | P53396 | 1/20 | 0.32 |
| ▸ | TUBB1 | Q9H4B7 | 1/20 | 0.32 |
| ▸ | CHRNA7 | P36544 | 1/20 | 0.31 |
| ▸ | HTR3A | P46098 | 1/20 | 0.31 |
| ▸ | PARP1 | P09874 | 1/20 | 0.30 |
| ▸ | KDM4E | B2RXH2 | 1/20 | 0.30 |
| ▸ | ALDH1A1 | P00352 | 1/20 | 0.30 |
| ▸ | TP53 | P04637 | 1/20 | 0.30 |
| ▸ | HPGD | P15428 | 1/20 | 0.30 |
| ▸ | HSD17B10 | Q99714 | 1/20 | 0.30 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL30705789 | 0.86 | MEP1B (0.32) | MEP1BACLYTUBB1CHRNA7HTR3A | |
| SCHEMBL30186608 | 0.80 | TUBB1 (0.35) | MEP1BACLYTUBB1CHRNA7HTR3A | |
| SCHEMBL30705764 | 0.79 | FABP4 (0.36) | ACLYPARP1KDM4EALDH1A1 | |
| SCHEMBL30705793 | 0.69 | ABCB1 (0.38) | ACLYTUBB1 | |
| SCHEMBL24020799 | 0.66 | ACLY (0.47) | ACLY | |
| SCHEMBL30310356 | 0.66 | ACLY (0.47) | ACLY | |
| SCHEMBL30705792 | 0.65 | FABP4 (0.36) | ACLYPARP1KDM4EALDH1A1 | |
| SCHEMBL30310460 | 0.64 | ACLY (0.48) | ACLY | |
| SCHEMBL24112566 | 0.64 | ACLY (0.48) | ACLY | |
| SCHEMBL25335851 | 0.63 | BUB1 (0.40) | ACLYTUBB1PARP1ALDH1A1 |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 1 patent. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| CN-111954525-B | Prodrugs of fused bicyclic C5aR antagonists | 凯莫森特里克斯股份有限公司 | 2023-12-26 | — | — | CN | disclosed |